Abstract
Clericusio syndrome is a rare genetic disease belonging to the group of congenital neutropenias, first described by S. Clericuzio et al. in 1991, in 14 patients from the Navajo tribe. It is characterized by poikiloderma and neutropenia, with recurrent infections and a high risk of developing myelodysplastic syndrome. Approaches to therapy are not optimized due to the rarity of this pathology. The article provides an overview of the data on the disease available to date, and discusses the case of Clericusio syndrome in a 5-year-old boy, from an early age observed in Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Parents gave their permission for using personal data for clinical research and publications.
Highlights
ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им
Это заболевание характеризуется пойкилодермой и нейтропенией с рецидивирующими инфекциями и высоким риском развития миелодиспластического синдрома
The article provides an overview of the data on the disease available to date, and discusses the case of Clericusio syndrome in a 5-year-old boy, from an early age observed in Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
Summary
ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. В статье приведен обзор имеющихся на сегодняшний день данных об этом заболевании, обсуждается случай синдрома Клерикузио у мальчика 5 лет, с раннего возраста наблюдающегося в НМИЦ детской гематологии, онкологии и иммунологии им.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
